High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy
Supplemental materials for: Uldrick et al
Files in this Data Supplement:
Document 1. Supplemental table and figure (PDF, 87.7 KB)